Eman H Yousef

5PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 26, 2026
Silymarin and Zinc Oxide Nanoparticles Attenuate Experimental Colon Cancer in Rats Through Crosstalk of miR-192 and β-Catenin Pathways.

|Aug 27, 2026
Vardenafil Alleviates Doxorubicin-Induced Cardiotoxicity Associated with Restoration of the AMPK/SIRT1 Signaling Pathway.

|Aug 13, 2026
Norcantharidin Ameliorates Experimental Ulcerative Colitis Through Epigenetic and Metabolic Reprogramming Involving IL-6/DNMT1/SOCS3 and AMPK/SIRT1/FOXO3a-Nrf2 Signaling.

|Sep 15, 2025
Co-administration of Spirulina and L-carnitine preserves ovarian reserve in a rat model of premature ovarian insufficiency via SIRT1 regulation of oxidative stress, inflammation, and apoptosis.

Eman M Embaby, Gehad E Elshopakey, Aya Megahed

|Apr 08, 2020
Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma.

Eman H Yousef, Mohamed E El-Mesery, Maha R Habeeb

Pageof 1

Frequent Collaborators

1 joint publications

Mohamed E El-Mesery

1 joint publications

Eman M Embaby

1 joint publications

Gehad E Elshopakey

1 joint publications

Mamdouh Eldesoqui